A new venture investment company is funding start-ups at their earliest stages, with a goal of increasing support for entrepreneurs from all backgrounds. . . . → Read More: Early Venture Investors Aim for Diverse Entrepreneurs
|
|||||
|
       
  |
Retailing and web services giant Amazon plans to invest $2 billion in sustainable technologies to meet the company’s goal of becoming carbon neutral by 2040. . . . → Read More: Amazon Opens $2 Billion Climate Investment Fund 
A biotechnology company creating engineered cells with modified genes for treating disease is raising $700 million in its first venture finance round. . . . → Read More: Gene, Cell Therapy Start-Up Gains $700M in Early Funds  One comment - (Comments are closed)  Finance  biomedical, biotechnology, entrepreneurs, equity, investment, life sciences, manufacturing, pharmaceuticals, stem cells, university, venture capital 
A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round. . . . → Read More: Crispr Heart Disease Start-Up Raises New $63M One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, heart disease, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
A new company spun off from University of Oxford is developing a stable and sensitive blood test to detect multiple types of cancer in their early stages. . . . → Read More: Start-Up Creating a Simpler, Stable Liquid Biopsy Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, medical device, physical sciences, U.K., university, venture capital 
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal. . . . → Read More: Biotechs Apply Crispr Gene-Editing for Hemophilia 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, genomics, investment, licensing, life sciences, pharmaceuticals, preclinical 
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch 
A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds One comment - (Comments are closed) Finance biomedical, biotechnology, Canada, Covid-19, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital 
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, FDA, genomics, investment, licensing, life sciences, merger, pharmaceuticals 
A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing. . . . → Read More: Psychiatric Drug Maker Raises $80M in Venture Funds Comments are closed Finance, New products biomedical, clinical trials, entrepreneurs, equity, Europe, investment, life sciences, pharmaceuticals, psychiatric, U.K., venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||